LBRX LB PHARMACEUTICALS INC
Health Care · Russell 2000
Next earnings: Thu 12 Nov 2026 · estimated
What 15 analyst firms say about LB PHARMACEUTICALS INC: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 16 analyst/firm records · 15 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8055
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8056
Recent analyst activity · last 90 days
Our tracked history has 15 reports on LBRX from 13 analyst firms in the last 90 days (15 firms in the past year).
Comparing each firm's latest target with its previous one: 4 raised their price target, 1 left it unchanged and 5 have their first observed target in the past year.
Ratings, latest available report against the previous one: 0 upgrades and 1 downgrade.
Latest observed target change: HC Wainwright raised its target from $45.00 (set 27 Apr 2026) to $60.00 on 24 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| BMO Capital Markets | Evan Seigerman | Buy | 20 Jul 2026 | 54.00 USD |
| BMO Capital Markets | Malcolm Hoffman | Buy | 12 Aug 2026 | 54.00 USD |
| Canaccord Genuity | Sumant Kulkarni | Buy | 9 Oct 2026 | 65.00 USD |
| Clear Street LLC | Kaveri Pohlman | Buy | 26 May 2026 | 69.00 USD |
| Craig-Hallum | Adam Vogel | Buy | 12 Aug 2026 | 45.00 USD |
| Guggenheim | Delma Caiati | Buy | 12 Oct 2026 | 80.00 USD · 6 Oct 2026 |
| H.C. Wainwright | Raghuram Selvaraju | Buy | 12 Oct 2026 | Conflicting reports · excluded |
| Leerink Partners | Marc Goodman | Buy | 11 Aug 2026 | 55.00 USD |
| Needham | Ami Fadia | Buy | 2 Oct 2026 | 68.00 USD |
| Piper Sandler | Yasmeen Rahimi | Buy | 27 Oct 2026 | 78.00 USD |
| Raymond James | Unnamed analyst | Buy | 12 Oct 2026 | — |
| Roth Capital | Boobalan Pachaiyappan | Hold | 5 Oct 2026 | 35.00 USD |
| Stifel | Paul Matteis | — | 13 Aug 2026 | 53.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Aug 2026 | — |
| Wolfe Research | Rudy Li | Buy | 7 Jul 2026 | 45.00 USD |
| Data feed RESEARCH | Research Team | Sell | 12 Oct 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:08 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.